Doceree raises US$ 35 million in Series B Funding
Capital raise to accelerate product and technology development and support expansion efforts to reshape communications to HCPs across the globe
Capital raise to accelerate product and technology development and support expansion efforts to reshape communications to HCPs across the globe
The investment will help the company meet soaring demand for user-friendly oral dosage form development and manufacturing
Commenced operations in flood-affected Himachal Pradesh
Also to be launched Scheme for promotion of Research and Innovation in Pharma MedTech Sector (PRIP)
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD)
Lupin has been exclusively marketing these brands in the Indian market since July 2021
With this, the company has secured 511 marketing approvals for its oncology products across 66 countries
The centralized marketing authorization granted by the EC is valid in all EU Member States as well as in the European Economic Area (EEA) countries Iceland, Liechtenstein and Norway
Reinforces Henkel commitment to supporting customers and ecosystem in medical healthcare
Fillauer recently announced the launch of the first-ever bio-attributed prosthetic foot shell
Subscribe To Our Newsletter & Stay Updated